Live from the NIH registry
Studies recruiting near Youngstown right now
Top 25 of 80 recruiting studies, sorted by proximity — each links to its official registry page
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Biochemically Recurrent Prostate Carcinoma, Metastatic Prostate Carcinoma
Phase 3
Interventional 804 participants sought
UPMC Cancer Center at UPMC Horizon — Farrell, Pennsylvania (11.0 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Ovarian Carcinoma
N/A
Interventional 1,956 participants sought
Aultman Alliance Community Hospital — Alliance, Ohio (27.1 mi)
· Sponsor: NRG Oncology
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum
N/A
Interventional 9,500 participants sought
Saint Elizabeth Youngstown Hospital — Youngstown, Ohio (0.2 mi)
· Sponsor: NRG Oncology
An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorectal Cancer Who Have Cancer Cachexia.
Colorectal Cancer, CRC (Colorectal Cancer)
Phase 2
Interventional 136 participants sought
NGM Clinical Study Site — Youngstown, Ohio (0.2 mi)
· Sponsor: NGM Biopharmaceuticals, Inc
Effects of Miricell Supplementation on Biomarkers of Healthy Aging and Autophagy
Autophagy, Healthy Aging
N/A
Interventional 70 participants sought
The Center for Applied Health Sciences — Canfield, Ohio (7.9 mi)
· Sponsor: Nutraland USA, Inc.
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer
Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7
Phase 2, Phase 3
Interventional 613 participants sought
UPMC Cancer Center at UPMC Horizon — Farrell, Pennsylvania (11.0 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
Acral Lentiginous Melanoma, Clinical Stage IV Cutaneous Melanoma AJCC v8
Phase 2
Interventional 112 participants sought
Saint Elizabeth Youngstown Hospital — Youngstown, Ohio (0.2 mi)
· Sponsor: SWOG Cancer Research Network
Evaluate the Effects of Citicoline on Mood in Healthy Adults
Healthy
N/A
Interventional 90 participants sought
The Center for Applied Health Sciences — Canfield, Ohio (7.9 mi)
· Sponsor: Kirin Holdings Company, Limited
Integrated Cancer Repository for Cancer Research
Multiple conditions
N/A
Observational 999,999 participants sought
Aultman Alliance Community Hospital — Alliance, Ohio (27.1 mi)
· Sponsor: University of Nebraska
Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer
Resectable Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8
Phase 3
Interventional 1,100 participants sought
Saint Elizabeth Youngstown Hospital — Youngstown, Ohio (0.2 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Stage III Colon Cancer
Phase 2, Phase 3
Interventional 1,912 participants sought
Saint Elizabeth Youngstown Hospital — Youngstown, Ohio (0.2 mi)
· Sponsor: NRG Oncology
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain
Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma
Phase 3
Interventional 269 participants sought
Saint Elizabeth Youngstown Hospital — Youngstown, Ohio (0.2 mi)
· Sponsor: NRG Oncology
Long-Term Follow-up Study of Cantharidin (YCANTH [VP-102/TO-208]) in Patients With Common Warts (Verruca Vulgaris)
Common Warts (Verruca Vulgaris), Common Warts
Phase 3
Interventional 250 participants sought
Optima Research Boardman — Boardman, Ohio (5.3 mi)
· Sponsor: Verrica Pharmaceuticals Inc.
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
Plasma Cell Myeloma
Phase 3
Interventional 510 participants sought
Saint Elizabeth Youngstown Hospital — Youngstown, Ohio (0.2 mi)
· Sponsor: SWOG Cancer Research Network
Phase 2/3 Efficacy and Safety of PP405 in Adult Males
Androgenetic Alopecia
Phase 2, Phase 3
Interventional 600 participants sought
Optima Research Boardman — Boardman, Ohio (5.3 mi)
· Sponsor: Pelage Pharmaceuticals, Inc.
The Lilac Device Trial - IMPACT: A Clinical Investigation on IMproving Peripheral Neuropathy Induced by Chemotherapy With Advanced Compression Technology - A Safety and Efficacy Study
Chemotherapy Induced Peripheral Neuropathy (CIPN)
N/A
Interventional 142 participants sought
Mercy Health St. Elizabeth Hospital — Youngstown, Ohio (0.2 mi)
· Sponsor: Luminate Medical, Inc.
Safety & Effectiveness of Autologous Regenerative Cell Therapy on Pain & Inflammation of Osteoarthritis of the Knee
Osteoarthritis
Phase 2
Interventional 4,000 participants sought
VivaTech International, Inc. — Grove City, Pennsylvania (29.3 mi)
· Sponsor: VivaTech International, Inc.
Chemotherapy Before Surgery and Radiation Therapy or Surgery and Radiation Therapy Alone in Treating Patients With Nasal and Paranasal Sinus Cancer That Can Be Removed by Surgery
Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7, Stage IVA Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7
Phase 2
Interventional 82 participants sought
UPMC Jameson — New Castle, Pennsylvania (16.9 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
Breast Cancer, Early Breast Cancer
Phase 3
Interventional 5,500 participants sought
Research Site — Youngstown, Ohio (0.2 mi)
· Sponsor: AstraZeneca
E-Mindfulness Approaches for Living After Breast Cancer
Breast Cancer, Depression
Phase 3
Interventional 402 participants sought
Saint Elizabeth Youngstown Hospital — Youngstown, Ohio (0.2 mi)
· Sponsor: NRG Oncology
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
Metastatic Colorectal Carcinoma, Metastatic Malignant Neoplasm in the Liver
Phase 3
Interventional 408 participants sought
Saint Elizabeth Youngstown Hospital — Youngstown, Ohio (0.2 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8
Phase 2
Interventional 66 participants sought
UPMC Cancer Center at UPMC Horizon — Farrell, Pennsylvania (11.0 mi)
· Sponsor: SWOG Cancer Research Network
Family Communications After Genetic Testing
Colon Adenocarcinoma, Colorectal Adenocarcinoma
N/A
Interventional 4,186 participants sought
Saint Elizabeth Youngstown Hospital — Youngstown, Ohio (0.2 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Advanced Malignant Solid Neoplasm, Anatomic Stage III Breast Cancer AJCC v8
Phase 2
Interventional 2,900 participants sought
Saint Elizabeth Youngstown Hospital — Youngstown, Ohio (0.2 mi)
· Sponsor: National Cancer Institute (NCI)
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Lung Non-Small Cell Carcinoma, Lung Non-Small Cell Squamous Carcinoma
Phase 3
Interventional 1,210 participants sought
Saint Elizabeth Youngstown Hospital — Youngstown, Ohio (0.2 mi)
· Sponsor: National Cancer Institute (NCI)